Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

Published:2004-01 Issue:8 Volume:41 Page:797-806
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Pearlman David S.,Peden David,Condemi John J.,Weinstein Steven,White Martha,Baitinger Leslie,Scott Catherine,Ho Shu‐Yen,House Karen,Dorinsky Paul

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference20 articles.

1. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma

2. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid

3. Concurrent Use of Salmeterol with Inhaled Corticosteroids is More Effective than Inhaled Corticosteroid Dose Increases

4. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials and future perspectives of antiinflammatory agents;Recent Developments in Anti-Inflammatory Therapy;2023

2. Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings;Respiratory Medicine;2020-01

3. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events;Cochrane Database of Systematic Reviews;2018-12-03

4. Application of Indirect Comparison to the Drug Development Process: Forecasting Direct Comparison Study Results;The Journal of Clinical Pharmacology;2016-04-01

5. Addition of long-acting beta2 -agonists to inhaled corticosteroids for chronic asthma in children;Cochrane Database of Systematic Reviews;2015-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3